Dry Eye Syndrome Market 2024 Opportunity, Challenge, Drivers, Restraint, Trend, Demand and Global Business Growth by 2031 | Novartis AG, AbbVie, Inc., Sun Pharmaceutical Industries Ltd., Santen Pharmaceutical Co., Ltd

The Dry Eye Syndrome Market is anticipated to reach USD10.4 billion by 2031 from USD 5.9 billion in 2022, at a CAGR of 7.4% during the forecast period.

DataM Intelligence has published a new research report on "Dry Eye Syndrome Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Segmentation, CAGR, business revenue competitive positioning of key companies, investigating elements such as product offerings, pricing strategies, financial performance, product portfolios, growth initiatives, and geographical reach. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/dry-eye-syndrome-market

Dry eye syndrome is a common condition characterized by a deficiency in the quantity or quality of tears, leading to insufficient lubrication of the eye surface. This results in symptoms such as dryness, irritation, redness, a gritty sensation, and blurred vision. The condition can be caused by various factors, including environmental conditions, prolonged screen time, certain medications, aging, and underlying health issues. Treatment options for dry eye syndrome may include artificial tears, anti-inflammatory medications, lifestyle modifications, and, in more severe cases, procedures to enhance tear production or retention. Effective management aims to relieve symptoms and improve overall eye health.

Key Developments:

On May 18, 2023, Bausch + Lomb Corporation, a leading global eye health company, and Novaliq GmbH, a biopharmaceutical firm specializing in ocular therapeutics, announced that the U.S. Food and Drug Administration (FDA) approved MIEBO (perfluorohexyloctane ophthalmic solution; formerly known as NOV03) for treating the signs and symptoms of dry eye disease (DED). MIEBO is the first and only FDA-approved treatment that directly targets tear evaporation.

On February 3, 2022, the FDA authorized the first generic version of AbbVie Inc.'s Restasis, a medication designed to increase tear production in patients with dry eye conditions. The approval was granted to Viatris Inc., a company formed in 2020 from the merger of Mylan Pharmaceuticals and Pfizer Inc.'s off-patent medication division.

On November 11, 2022, Allysta Pharmaceuticals Inc. announced the completion of enrollment in its Phase 2b/3 trial (OASIS-1) for ALY688 Ophthalmic Solution, aimed at treating dry eye disease.

Research Process:

Both primary and secondary data sources have been used in the global Dry Eye Syndrome Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

List of the Key Players in the Dry Eye Syndrome Market:

Novartis AG, AbbVie, Inc., Sun Pharmaceutical Industries Ltd., Santen Pharmaceutical Co., Ltd., AFT Pharmaceuticals, Johnson & Johnson Services, Inc., Otsuka Pharmaceutical Co., Ltd., OASIS Medical, Oyster Point Pharma, Inc. and Bausch & Lomb.

Segment Covered in the Dry Eye Syndrome Market:

By Type: Aqueous deficiency, Evaporative

By Product: Anti-inflammatory Drugs, Lubricant Eye Drops, Punctal Plugs, Oral Omega Supplements, Others

By Dosage Form: Gels, Eye Solutions, Capsules & Tablets, Eye Drops, Ointments

By Sales Channel: Prescription, OTC

By Distribution channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies

Regional Analysis:

The global Dry Eye Syndrome Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/dry-eye-syndrome-market

Regional Analysis:

The global Dry Eye Syndrome Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Dry Eye Syndrome Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Dry Eye Syndrome manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Dry Eye Syndrome in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Have any Query? Talk to our Expert @ https://www.datamintelligence.com/enquiry/dry-eye-syndrome-market

Frequently Asked Questions

Q1) How Big is the Dry Eye Syndrome Market?

A) The Global Dry Eye Syndrome Market reached USD 5.9 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 10.4 billion by 2031. The global dry eye syndrome market is expected to exhibit a CAGR of 7.4% during the forecast period (2024-2031).

Q2) Who are the key players of Dry Eye Syndrome Market?

A) Key players are Novartis AG, AbbVie, Inc., Sun Pharmaceutical Industries Ltd., Santen Pharmaceutical Co., Ltd., AFT Pharmaceuticals, Johnson & Johnson Services, Inc., Otsuka Pharmaceutical Co., Ltd., OASIS Medical, Oyster Point Pharma, Inc. and Bausch & Lomb.

Q3) What are the regions covered in this report?

A) The global Dry Eye Syndrome Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa

4) What are the Segments Coverd in this report?

A) The Dry Eye Syndrome market is segmented as Type, Product, Dosage Form, Sales Channel, Distribution Channel, and Region

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.